We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Nordic EMBL Partnership for Molecular Medicine
News

New Nordic EMBL Partnership for Molecular Medicine

New Nordic EMBL Partnership for Molecular Medicine
News

New Nordic EMBL Partnership for Molecular Medicine

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "New Nordic EMBL Partnership for Molecular Medicine"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The European Molecular Biology Laboratory (EMBL), the University of Helsinki, Finland, the University of Oslo, Norway, and Umea University, Sweden, have officially launched their new Nordic EMBL Partnership for Molecular Medicine.

The agreement will encourage scientific exchange and collaboration between the partners and will facilitate access to respective scientific infrastructure, facilities and services for an initial period of five years.

The partnership between EMBL, the Institute for Molecular Medicine Finland, the Centre for Molecular Medicine Norway and the Laboratory for Molecular Infection Medicine Sweden is dedicated to molecular medicine, a growing field in the life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments.

EMBL’s recognized research strengths in the areas of molecular, cellular and developmental biology, bioinformatics and structural biology will be complemented by Norway’s expertise in molecular mechanisms of disease, Sweden’s focus on microbial pathogenicity and molecular infection medicine and Finland’s strength in genetic epidemiology.

The agreement will facilitate access to scientific infrastructure, including databases, facilities and instrumentation, as well as to services and training activities provided by the partners. The partnership will result in the adoption of the EMBL model for international recruitment, staff turnover and scientific reviews to the Nordic nodes.

The coordination between the Nordic nodes and EMBL will be overseen by a steering committee constituted by two representatives from each node. Scientific progress will be reviewed regularly by a committee of external experts. In addition to their partnership with EMBL the individual Nordic research centers will engage in collaborations with other national partners, including research and public health institutes, hospitals and research councils, to establish an extensive Nordic network for molecular medicine.

Advertisement